Medical Condition News

RSS

Change in CT protocols could decrease radiation dose to the breast and lungs

Carefully consider the radiation dose to the breast and lungs before deciding which CT protocol to use for thoracic imaging of individual patients, a new study cautions.

1 Oct 2011

The Polyclinic participates in major international HDL clinical research study

The Polyclinic is participating in a major international clinical research study aimed at raising HDL (good cholesterol) levels.

1 Oct 2011

Combination therapy improves outcomes for liver cancer patients: Study

A combination of an oral drug, called sorafenib, and a method for injecting microbeads of chemotherapy directly into tumors has been proven safe for liver cancer patients and may improve outcomes for those who have these fast-growing, deadly tumors whose numbers are on the rise in the U.S.

1 Oct 2011

Jeffrey C. Hall, Michael W. Young and Michael Rosbash to receive 2011 Louisa Gross Horwitz Prize

Columbia University will award the 2011 Louisa Gross Horwitz Prize to Jeffrey C. Hall, Michael Rosbash, and Michael W. Young for their work on the molecular basis of circadian rhythms, the first demonstration of a molecular mechanism for behavior.

1 Oct 2011

Third Annual Cape Cod Walk 'n' Roll for FSH Muscular Dystrophy on October 1

Tomorrow, October 1, 2011, FSHD patients and their friends, advocates, and families will join in the Third Annual Cape Cod Walk 'n' Roll for FSHD.

1 Oct 2011

Planned clinical trial of Adeona's zinc-based therapy for ALS patients to be featured at ALS Summit

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that its planned clinical trial of the Company's proprietary zinc-based therapy for patients suffering from amyotrophic lateral sclerosis, also known as Lou Gehrig's Disease, will be featured during the Hot Topics session at the 2011 California ALS Research Summit on Saturday, October 1, 2011.

1 Oct 2011

Bristol-Myers to present abstracts on research in liver disease at The Liver Meeting 2011

Bristol-Myers Squibb Company announced today that 22 abstracts on the Company's research in liver disease have been accepted for presentation at The Liver Meeting 2011, the 62nd annual meeting of the American Association for the Study of Liver Diseases, in San Francisco, November 4 - 8.

1 Oct 2011

Researchers identify gene responsible for starting the biological clock

Ever wondered why you wake up in the morning ---- even when the alarm clock isn't making jarring noises? Wonder no more. Researchers at the Salk Institute for Biological Studies have identified a new component of the biological clock, a gene responsible for starting the clock from its restful state every morning.

1 Oct 2011

Dialysis patients with kidney failure more likely to develop serious complications from flu

For most people, the flu is a temporary setback that makes them feel under the weather for a week or two. For dialysis patients with kidney failure, however, the flu is a serious health threat that can lead to pneumonia and other life-threatening complications.

1 Oct 2011

DMEI dedicates new $46M research and clinical facility

Officials from the Dean McGee Eye Institute today announced the dedication of the Institute's new $46 million, five-story, 78,000-square-foot, world-class research and clinical facility.

1 Oct 2011

Survey calls for greater clinical consensus on diagnosis, treatment of breakthrough cancer pain

Today, the results from a European Survey of Oncology Nurse Breakthrough Cancer Pain Practices were presented for the first time at The European Multidisciplinary Cancer Congress in Stockholm.

1 Oct 2011

Study confirms that CNAP-PPV method offers precise therapy control during surgery

The well-established high tech company CNSystems once again attracts international attention with a big mile stone. The Bordeaux University Hospital (France) confirms that the validated CNAP blood pressure wave offers the possibility of precise therapy control during surgery.

1 Oct 2011

CorMedix to primarily focus on commercialization of Neutrolin in Europe

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced it has decided based upon recent developments to primarily focus on the commercialization of Neutrolin in Europe.

1 Oct 2011

Wireless Vital Signs Monitor for trauma victims enters clinical trial phase

A collaboration among a medical device innovator, the U.S. Army Institute of Surgical Research (ISR), the nonprofit National Trauma Institute and the State of Texas enters its final phase as the FDA-approved Wireless Vital Signs Monitor (WVSM) begins clinical trials this month in the Memorial Hermann Medical Center emergency department and on Houston Life Flight.

1 Oct 2011

UAB Comprehensive Cancer Center receives NCI grant to renew support for cancer research program

The University of Alabama at Birmingham Comprehensive Cancer Center has received a five-year, $27.5 million Cancer Center Support Grant from the National Cancer Institute to renew support for its cancer research program through 2016.

1 Oct 2011

NIH's fourth Symposium on Cardiovascular Regenerative Medicine to be held Oct. 4-5

Advances in tissue engineering and stem cell therapies will be among the research topics discussed during the National Institutes of Health's fourth Symposium on Cardiovascular Regenerative Medicine, which will be held Oct. 4-5.

1 Oct 2011

Novel bipartite gene therapy for retinitis pigmentosa

In a paper published in the October 2011 issue of Experimental Biology and Medicine, a team of researchers at Columbia University Medical Center led by Stephen Tsang, MD, Ph.D have achieved temporary functional preservation of photoreceptors in a mouse model for retinitis pigmentosa (RP) using novel bipartite gene therapy.

1 Oct 2011

New AAOS guideline recommends how to reduce DVT, PE after joint replacement surgery

An updated clinical practice guideline released last week by the American Academy of Orthopaedic Surgeons (AAOS) Board of Directors recommends how to reduce the likelihood of blood clots after hip or knee replacement surgery, procedures that more than 800,000 Americans undergo each year. The new guideline suggests use of preventive treatments and advises against routinely screening patients after surgery using ultrasound imaging.

1 Oct 2011

Study calls for review of current treatment strategies, more research into stroke prevention

Doctors are underutilising crucial medication to prevent deadly strokes in those with a common type of heart condition, new research says, leading to fresh calls for a review of current treatment strategies and more research into stroke prevention.

1 Oct 2011

Researchers identify protein-based blood biomarkers in patients treated with EPO

Biomarkers in the bloodstream could provide a rapid assessment of therapeutic intervention in ischemic stroke and allow patient stratification

1 Oct 2011

Medical Condition News

Change in CT protocols could decrease radiation dose to the breast and lungs

The Polyclinic participates in major international HDL clinical research study

Combination therapy improves outcomes for liver cancer patients: Study

Jeffrey C. Hall, Michael W. Young and Michael Rosbash to receive 2011 Louisa Gross Horwitz Prize

Third Annual Cape Cod Walk 'n' Roll for FSH Muscular Dystrophy on October 1

Planned clinical trial of Adeona's zinc-based therapy for ALS patients to be featured at ALS Summit

Bristol-Myers to present abstracts on research in liver disease at The Liver Meeting 2011

Researchers identify gene responsible for starting the biological clock

Dialysis patients with kidney failure more likely to develop serious complications from flu

DMEI dedicates new $46M research and clinical facility

Survey calls for greater clinical consensus on diagnosis, treatment of breakthrough cancer pain

Study confirms that CNAP-PPV method offers precise therapy control during surgery

CorMedix to primarily focus on commercialization of Neutrolin in Europe

Wireless Vital Signs Monitor for trauma victims enters clinical trial phase

UAB Comprehensive Cancer Center receives NCI grant to renew support for cancer research program

NIH's fourth Symposium on Cardiovascular Regenerative Medicine to be held Oct. 4-5

Novel bipartite gene therapy for retinitis pigmentosa

New AAOS guideline recommends how to reduce DVT, PE after joint replacement surgery

Study calls for review of current treatment strategies, more research into stroke prevention

Researchers identify protein-based blood biomarkers in patients treated with EPO

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News